Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late‐onset Sepsis
- 10 July 2014
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 29 (5) , 347-352
Abstract
Background Soluble urokinase plasminogen activator receptor (suPAR) has been studied in a variety of diseases. The aim of the study is to investigate the levels of suPAR in neonates with sepsis. Methods The infants enrolled to this prospective study were classified into four groups. Group 1, 2, and 3 were referred as the patient groups (40 infants), and group 4 was referred as control group (26 infants). Blood samples for whole blood count, C‐reactive protein (CRP), suPAR and blood culture were obtained before initiating antimicrobial therapy, and two further samples were obtained on day 3 and at the end of the treatment for CRP and suPAR. Results The mean gestational ages of patient and control groups was similar. The median level of initial suPAR was 18.8 ng/mL (range 6.8–30.1 ng/mL) in the patient groups, and 6.0 ng/mL (range 3.7–10.8 ng/mL) in the control group (P < 0.001). A significant decrease in suPAR level was observed from the inclusion to the third day and end of the treatment (P < 0.001). The area under the curve (AUC) for suPAR is 0.959 (95% Cl: 0.919–0.999) and for CRP is 0.782 (95% Cl: 0.669–0.895). At a cut‐off value of 11.3 ng/mL for suPAR the specificity was 100%, and the sensitivity was 82.5%. There was a positive correlation between laboratory values of CRP and suPAR (r: 0.359, P = 0.003). Conclusion This is the first study that investigated the levels of suPAR in neonates and our results demonstrate that suPAR is a powerful marker of inflammation in infants with sepsis.Keywords
Funding Information
- Ankara University Research Funding Center (10B3330012)
This publication has 27 references indexed in Scilit:
- suPAR as a prognostic biomarker in sepsisBMC Medicine, 2012
- The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe SepsisBiomarker Insights, 2012
- The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndromeClinical Biochemistry, 2011
- Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patientsCritical Care, 2011
- Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV‐infected patients receiving highly active antiretroviral therapyJournal of Medical Virology, 2007
- Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective studyCritical Care, 2007
- Diagnostic markers for neonatal sepsisCurrent Opinion in Pediatrics, 2006
- Clinical Trials for Evaluating Diagnostic Markers of Infection in NeonatesNeonatology, 2005
- The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortalityClinical Microbiology and Infection, 2004